Combining a dopamine agonist and selective serotonin reuptake inhibitor for the treatment of depression: A double-blind, randomized pilot study
- 1 July 2013
- journal article
- research article
- Published by Elsevier in Journal of Affective Disorders
- Vol. 149 (1-3) , 319-325
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- The Treatment of Restless Legs Syndrome and Periodic Limb Movement Disorder in Adults—An Update for 2012: Practice Parameters with an Evidence-Based Systematic Review and Meta-AnalysesSLEEP, 2012
- Update to the AASM Clinical Practice Guideline: “The Treatment of Restless Legs Syndrome and Periodic Limb Movement Disorder in Adults—An Update for 2012: Practice Parameters with an Evidence-Based Systematic Review and Meta-Analyses”SLEEP, 2012
- Role of Pramipexole in the Management of Parkinsonʼs DiseaseCNS Drugs, 2010
- Duration and adherence of antidepressant treatment (2003 to 2007) based on prescription databaseEuropean Psychiatry, 2010
- Duloxetine versus escitalopram and placebo in the treatment of patients with major depressive disorder: onset of antidepressant action, a non-inferiority studyCurrent Medical Research and Opinion, 2007
- A double-blind, randomized, parallel-group, flexible-dose study to evaluate the tolerability, efficacy and effects of treatment discontinuation with escitalopram and paroxetine in patients with major depressive disorderInternational Clinical Psychopharmacology, 2006
- New approaches to antidepressant drug discovery: beyond monoaminesNature Reviews Neuroscience, 2006
- Venlafaxine extended release versus conventional antidepressants in the remission of depressive disorders after previous antidepressant failure: ARGOS studyDepression and Anxiety, 2005
- Are Dopamine Receptor Agonists Neuroprotective in Parkinson??s Disease?Drugs & Aging, 2001
- A New Depression Scale Designed to be Sensitive to ChangeThe British Journal of Psychiatry, 1979